1
|
Trembovetskaya EM. [DEFORMITY OF LEFT VENTRICLE WALLS IN PATIENTS WITH AORTAL VALVE STENOSIS]. Klin Khir 2015:41-43. [PMID: 26263642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Parameters of longitudinal deformity of left ventricle walls in patients, suffering aortal valve stenosis (AVS), were analyzed. While the process of heart contraction in norm and in AVS occurs, longitudinal deformity is expressed maximally in its apical divisions. AVS deformity of apical divisions of left ventricle, as well as middle divisions of interventricular septum and lower wall, practically did not differ from such in norm, and deformity of basal divisions of all walls and middle divisions of posterior, lateral and anterior walls of left ventricle was trustworthy less than a norm. Thus, a reduction of the deformity indices in basal divisions of left ventricle and middle segments of its posterior, lateral and anterior walls in patients, suffering AVS with preserved output fraction, precedes the disorders of its hemodynamics and constitutes a predictor for the cardiac output reduction.
Collapse
|
2
|
Plocarová K. [Inflammatory borrelia - associated dilated cardiomyopathy]. Vnitr Lek 2013; 59:1107-1110. [PMID: 24350941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
A case of a 44-year-old female patient is described, examined for several weeks with shortness of breath and the symptoms of heart decompensation after repeated untreated respiratory infections. Echocardiographically determined diffuse hypokinesis of dilated left ventricle with ejection fraction of 20%. Coronarographic examination without any significant finding at the coronary bed. MRI of the myocardium supported the suspicion of myocarditis, followed by the endomyocardial biopsy with electron microscopic evidence of borrelia fragments. After the causal and symptomatic treatment, the patient experienced significant clinical improvement and full normalisation of the finding.
Collapse
|
3
|
Affiliation(s)
- R Fox
- Division of Women's and Children's Health, Taunton and Somerset Hospital, Taunton, Somerset, UK.
| |
Collapse
|
4
|
Seguchi O, Takashima S, Yamazaki S, Asakura M, Asano Y, Shintani Y, Wakeno M, Minamino T, Kondo H, Furukawa H, Nakamaru K, Naito A, Takahashi T, Ohtsuka T, Kawakami K, Isomura T, Kitamura S, Tomoike H, Mochizuki N, Kitakaze M. A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest 2007; 117:2812-24. [PMID: 17885681 PMCID: PMC1978424 DOI: 10.1172/jci30804] [Citation(s) in RCA: 126] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2006] [Accepted: 06/26/2007] [Indexed: 02/04/2023] Open
Abstract
Marked sarcomere disorganization is a well-documented characteristic of cardiomyocytes in the failing human myocardium. Myosin regulatory light chain 2, ventricular/cardiac muscle isoform (MLC2v), which is involved in the development of human cardiomyopathy, is an important structural protein that affects physiologic cardiac sarcomere formation and heart development. Integrated cDNA expression analysis of failing human myocardia uncovered a novel protein kinase, cardiac-specific myosin light chain kinase (cardiac-MLCK), which acts on MLC2v. Expression levels of cardiac-MLCK were well correlated with the pulmonary arterial pressure of patients with heart failure. In cultured cardiomyocytes, knockdown of cardiac-MLCK by specific siRNAs decreased MLC2v phosphorylation and impaired epinephrine-induced activation of sarcomere reassembly. To further clarify the physiologic roles of cardiac-MLCK in vivo, we cloned the zebrafish ortholog z-cardiac-MLCK. Knockdown of z-cardiac-MLCK expression using morpholino antisense oligonucleotides resulted in dilated cardiac ventricles and immature sarcomere structures. These results suggest a significant role for cardiac-MLCK in cardiogenesis.
Collapse
Affiliation(s)
- Osamu Seguchi
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Seiji Takashima
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Satoru Yamazaki
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Masanori Asakura
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Yoshihiro Asano
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Yasunori Shintani
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Masakatsu Wakeno
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Tetsuo Minamino
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Hiroya Kondo
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Hidehiko Furukawa
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Kenji Nakamaru
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Asuka Naito
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Tomoko Takahashi
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Toshiaki Ohtsuka
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Koichi Kawakami
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Tadashi Isomura
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Soichiro Kitamura
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Hitonobu Tomoike
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Naoki Mochizuki
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| | - Masafumi Kitakaze
- Department of Cardiovascular Medicine, National Cardiovascular Center, Suita, Osaka, Japan.
Department of Cardiovascular Medicine and
Health Care Center, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Core Technology Research Laboratories, Sankyo Co. Ltd., Shinagawa, Tokyo, Japan.
Division of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Shizuoka, Japan.
Hayama Heart Center, Hayama, Kanagawa, Japan
| |
Collapse
|
5
|
Kempf T, Drexler H, Wollert KC. [Pathophysiology of heart failure]. Internist (Berl) 2007; 48:899-908. [PMID: 17712536 DOI: 10.1007/s00108-007-1929-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Chronic heart failure is a clinical syndrome and the final common pathway of different cardiac diseases. Heart failure is accompanied by activation of the renin-angiotensin-aldosterone-system and the adrenergic nervous system. In addition, recent data emphasize important roles of maladaptive intracellular signaling pathways, decreased capillary density, altered calcium handling, metabolic changes, genetic polymorphisms, and programmed cell death in the failing heart. In this context, traditional pathophysiological concepts, e. g. concerning the role of cardiac hypertrophy, had to be given up. Thus, an increasingly complex scenario emerges with interdependent changes on the biochemical, molecular, metabolic, and cellular level. Novel therapeutic strategies may soon be based on these new pathophysiological concepts.
Collapse
Affiliation(s)
- T Kempf
- Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland
| | | | | |
Collapse
|
6
|
Affiliation(s)
- S-D Chung
- Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, Ban Ciao, Taipei, Taiwan
| | | | | | | | | | | |
Collapse
|
7
|
|
8
|
Abstract
Changes in oxidative stress and apoptotic process were studied during the progression of a compensated hypertrophy to a decompensated heart failure in guinea pigs. Banding of the ascending aorta resulted in heart hypertrophy. At 10 wk, ventricle-to-body weight ratio and thickness of the interventricular septum as well as the left ventricular wall were increased significantly. Although fractional shortening and ejection fraction were decreased, there were no signs of heart failure. Furthermore, there was no increase in wet-to-dry weight ratios for the lungs and liver at this stage. However, at 20 wk, heart failure was characterized by a significant depression in heart function as indicated by a decrease in fractional shortening, and ejection fraction and a lesser increase in wall thickness from diastole to systole. Animals also showed clinical signs of heart failure, and the wet-to-dry weight ratios of the lungs and liver were significantly higher. Cardiomyocyte oxidative stress was significantly higher in the 20-wk aortic-banded group. The ratio of Bax to Bcl-xl showed an increase at 10 wk, and there was a further increase at 20 wk. Mitochondrial membrane potential in the aortic-banded animals was significantly decreased at 10 and 20 wk. Cytochrome c levels were higher in the cytosol compared with the mitochondria, leading to a considerable increase in the expression of p17 subunit of caspase-3. At 20 wk, both early and late stages of apoptosis were observed in isolated cardiomyocytes. It is suggested that an increase in oxidative stress initiates mitochondrial death pathway during the hypertrophic stage, leading to apoptosis and heart failure at a later stage.
Collapse
Affiliation(s)
- A K Sharma
- Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada
| | | | | | | |
Collapse
|
9
|
Daniels MCG, Naya T, Rundell VLM, de Tombe PP. Development of contractile dysfunction in rat heart failure: hierarchy of cellular events. Am J Physiol Regul Integr Comp Physiol 2007; 293:R284-92. [PMID: 17363676 DOI: 10.1152/ajpregu.00880.2006] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The cellular mechanisms underlying the development of congestive heart failure (HF) are not well understood. Accordingly, we studied myocardial function in isolated right ventricular trabeculae from rats in which HF was induced by left ventricular myocardial infarction (MI). Both early-stage (12 wk post-MI; E-pMI) and late, end-stage HF (28 wk post-Mi; L-pMI) were studied. HF was associated with decreased sarcoplasmic reticulum Ca2+ ATPase protein levels (28% E-pMI; 52% L-pMI). HF affected neither sodium/calcium exchange, ryanodine receptor, nor phospholamban protein levels. Twitch force at saturating extracellular [Ca2+] was depressed in HF (30% E-pMI; 38% L-pMI), concomitant with a marked increase in sensitivity of twitch force toward extracellular [Ca2+] (26% E-pMI; 68% L-pMI). Ca2+-saturated myofilament force development in skinned trabeculae was unchanged in E-pMI but significantly depressed in L-pMI (45%). Tension-dependent ATP hydrolysis rate was depressed in L-pMI (49%), but not in E-pMI. Our results suggest a hierarchy of cellular events during the development of HF, starting with altered calcium homeostasis during the early phase followed by myofilament dysfunction at end-stage HF.
Collapse
Affiliation(s)
- Marcel C G Daniels
- Department of Physiology and Biophysics MC901, Center for Cardiovascular Research, University of Illinois at Chicago, 835 S. Wolcott Ave., Chicago, IL 60612, USA
| | | | | | | |
Collapse
|
10
|
Abstract
AIMS Brain-type alpha-subunit isoforms of the Na(+) channel are present in various cardiac tissue types and may control pacemaker activity and excitation-contraction coupling. Heart failure (HF) alters pacemaker activity and excitation-contraction coupling. Here, we studied whether HF alters brain-type Na(+) channel properties. METHODS AND RESULTS HF was induced in rabbits by volume/pressure overload. Na(+) currents of ventricular myocytes were recorded in the cell-attached mode of the patch-clamp technique using macropatches. Macropatch recordings were conducted from the middle portions of myocytes or from intercalated disc regions between cell pairs. Both areas exhibited a fast activating and inactivating current, 8.5 times larger in intercalated disc regions. Tetrodotoxin (TTX) (50 nM) did not block currents in the intercalated disc regions, but did block in the middle portions, indicating that the latter currents were TTX-sensitive brain-type Na(+) currents. Macropatch recordings from these regions were used to study the effects of HF on brain-type Na(+) current. Neither current density nor gating properties (activation, inactivation, recovery from inactivation, slow inactivation) differed between CTR and HF. CONCLUSION The density and gating properties of brain-type Na(+) current are not altered in our HF model. In the volume/pressure-overload rabbit model of HF, the role of brain-type Na(+) current in HF-induced changes in excitation-contraction coupling is limited.
Collapse
Affiliation(s)
- Arie O Verkerk
- Heart Failure Research Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| | | | | | | |
Collapse
|
11
|
Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, Schiavone A, Micheletti R, Ferrari P, Fogari R, Perlini S. Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. Am J Hypertens 2007; 20:663-9. [PMID: 17531925 DOI: 10.1016/j.amjhyper.2007.01.016] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2006] [Revised: 10/26/2006] [Accepted: 01/19/2007] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND During the transition of pressure overload hypertrophy (POH) to heart failure (HF) there is intense interstitial cardiac remodeling, characterized by a complex balance between collagen deposition and degradation by matrix metalloproteases (MMPs). This study was aimed at investigating the process of cardiac remodeling during the different phases of the transition of POH to HF. METHODS Guinea pigs underwent thoracic descending aortic banding or sham operation. Twelve weeks after surgery, left-ventricular (LV) end-diastolic internal dimension and ventricular systolic pressure were measured by combined M-mode echocardiography and micromanometer cathetherization. The MMP activity, tissue-specific MMP inhibitors (TIMPs), and collagen fraction were evaluated in LV tissue samples by zymography, ELISA, and computer-aided analysis, respectively. RESULTS Banded animals were divided by lung weight values into either compensated left-ventricular hypertrophy (LVH) or HF groups, as compared with sham-operated controls. All HF animals exhibited a restrictive pattern of Doppler transmitral inflow, indicative of diastolic dysfunction, and developed lung congestion. Compensated LVH was associated with increased MMP-2 activity, which was blunted after transition to HF, at a time when TIMP-2 levels and collagen deposition were increased. CONCLUSIONS The cardiac remodeling process that accompanies the development of POH is a phase-dependent process associated with progressive deterioration of cardiac function.
Collapse
MESH Headings
- Animals
- Blood Pressure/physiology
- Cardiac Output, Low/enzymology
- Cardiac Output, Low/pathology
- Cardiac Output, Low/physiopathology
- Cardiomyopathy, Dilated/enzymology
- Cardiomyopathy, Dilated/pathology
- Cardiomyopathy, Dilated/physiopathology
- Collagen/metabolism
- Disease Progression
- Echocardiography
- Guinea Pigs
- Heart Ventricles/metabolism
- Heart Ventricles/pathology
- Heart Ventricles/physiopathology
- Hypertrophy, Left Ventricular/enzymology
- Hypertrophy, Left Ventricular/pathology
- Hypertrophy, Left Ventricular/physiopathology
- Male
- Matrix Metalloproteinases/metabolism
- Tissue Inhibitor of Metalloproteinases/metabolism
- Ventricular Dysfunction, Left/physiopathology
- Ventricular Remodeling/physiology
Collapse
Affiliation(s)
- Rossana Tozzi
- Clinica Medica II, Fondazione IRCCS San Matteo, University of Pavia, Pavia, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Nepomniashchikh LM. [Regenerative and plastic heart failure: molecular biological mechanisms and morphological bases]. Arkh Patol 2007; 69:3-12. [PMID: 17722586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
Regenerative and plastic heart failure resulted in impaired or inhibited biosynthetic processes (plastic metabolism) and hence decreased or ceased intracellular cardiomyocytic regeneration. Atrophic (involutional) processes of cardiomyocytes and their progressive deficiency due to apoptotic death (diffuse cardiomyocytic depopulation), accompanied by the development of diffuse cardiosclerosis play the key role in regenerative and plastic heart failure. Diffuse myocardial sclerosis may be regarded as a corrected compensatory connective tissue response to a pronounced decrease in muscle fiber mass. In anthracycline-induced cardiomyopathy, myocardial remodeling as a result of changes in the pattern of parenchymal and stromal interactions occurs in the dilatation mode and induces no severe cardiac deformation, which is a favorable factor in restoring the normal myocardial architectonics when regenerative processes are resumed.
Collapse
|
13
|
Kimura K, Yoon SH, Fukuda K, Kimura T, Takahashi K, Suzuki N, Imai A, Noma S. Cardiac "Bradykinesia" in advanced Parkinson's disease. Mov Disord 2007; 22:750-2. [PMID: 17299776 DOI: 10.1002/mds.21388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
14
|
Jahanyar J, Youker KA, Loebe M, Assad-Kottner C, Koerner MM, Torre-Amione G, Noon GP. Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart. J Surg Res 2007; 140:199-203. [PMID: 17418861 DOI: 10.1016/j.jss.2007.02.040] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2006] [Revised: 02/20/2007] [Accepted: 02/26/2007] [Indexed: 11/19/2022]
Abstract
BACKGROUND The role of cardiac mast cells (MCs) in the progression to heart failure has recently become increasingly evident. Cathepsin g is a neutrophil- and mast cell-derived protease, which can convert angiotensin I to angiotensin II and thereby activate the TGF-beta pathway, resulting in myocyte necrosis, hypertrophy, and increased fibrosis. This study focuses on mast cell-derived cathepsin g in the human heart during heart failure and following mechanical unloading by means of heart-assist devices (LVADs). MATERIALS AND METHODS Myocardial tissue was obtained from 10 patients with end-stage cardiomyopathy at the time of LVAD implantation (pre-LVAD) and following orthotopic heart transplantation (post-LAVD). In addition, biopsies of four normal hearts served as a control group. Paraffin-embedded sections were dual stained for cathepsin g and tryptase, a known marker for mast cells, using standard immunohistochemistry protocols. Total cathepsin g positive mast cells were counted. RESULTS No cathepsin g positive MCs were found in normal hearts. However, we found evidence for cathepsin g in cardiac MCs in heart failure tissues (pre-LVAD). During heart failure, 46% of total MCs were cathepsin g positive as compared to after mechanical unloading, where only 11% of total MCs were cathepsin g positive (P<0.001). CONCLUSION Heart failure causes an increase of myocardial MCs. We have provided evidence that cathepsin g positive MCs accumulate during heart failure and their total percentage decreases after ventricular unloading. This coincides with the decrease in myocyte necrosis, hypertrophy, and fibrosis. Thus, cathepsin g may play a role in the progression to heart failure by activating angiotensin II, leading to detrimental effects on the heart.
Collapse
Affiliation(s)
- Jama Jahanyar
- Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.
| | | | | | | | | | | | | |
Collapse
|
15
|
Rastan AJ, Lachmann N, Walther T, Doll N, Gradistanac T, Gommert JF, Lehmann S, Wittekind C, Mohr FW. Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO). Int J Artif Organs 2007; 29:1121-31. [PMID: 17219352 DOI: 10.1177/039139880602901205] [Citation(s) in RCA: 127] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
OBJECTIVES To assess the clinical sensitivity of causes of death, concomitant diseases and postoperative complications including thromboembolic events in ECMO patients. METHODS Between January 2000 and December 2004 154/202 patients (76.2%) died after postcardiotomy ECMO circulatory support. Autopsy was performed in 78 (50.6%) consecutive patients. Clinical and post-mortem data were prospectively recorded and compared concerning causes of death and postoperative complications including venous and arterial thromboembolisms and significant comorbidities. RESULTS Mean age was 62.1+/-11.3 years, ejection fraction was 43.4+/-17.3%. 39.7% were emergency operations including acute coronary syndrome in 25.6% and preoperative cardiogenic shock in 28.2%. Successful ECMO weaning rate was 43.6%. Mean postoperative survival was 11.3 days. Premortem unknown concomitant diseases were found in 63 patients (80.8%) with clinical relevance in 9 patients (11.5%). Clinically unrecognized postoperative complications were found in 59 patients (75.6%) including acute cerebral infarction (n=7), acute bowel ischemia (1), intestinal perforation (3), pneumonia (4), venous thrombus formation (25) and systemic thromboembolic events (24). Clinically based causes of death were cardiac in 62.8%, multi-organ failure in 10.3%, cerebral in 5.1%, respiratory in 10.3%, fatal pulmonary embolism in 2.6%, technical in 5.1%, and others in 3.8%. Unexpected causes of death were found by autopsy in 22 patients (28.2%) including myocardial infarction (n=5), acute heart failure (4), fatal pulmonary embolism (2), pneumonia (2), ARDS (1), lung bleeding (1), fatal cerebrovascular event (4) and multiorgan failure (3). CONCLUSIONS In ECMO patients major discrepancies between clinical and post-mortem examination were found. The true incidence of thromboembolic events is highly underestimated by clinical evaluation.
Collapse
Affiliation(s)
- A J Rastan
- University of Leipzig, Cardiac Surgery, Heart Center Leipzig, Leipzig, Germany.
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Abstract
Propofol is increasingly used for the treatment of status epilepticus due to the ease of use and tolerability, even if safety data from randomized clinical trials are lacking. An association of high infusion rates of propofol (>5 mg/kg/h) for more than 48 h and constellation of acidosis, rhabdomyolysis, and cardiovascular collapse has been reported in children, but has only been described in a few adult cases. We report a case and autopsy findings of an adult who developed rhabdomyolysis and cardiac failure after receiving propofol for status epilepticus. The patient became symptomatic within 55 h after initiation of propofol infusion. The maximal infusion rate did not exceed 7.2 mg/kg/h, and propofol in excess of 5mg/kg/h was infused for less than 20 h. Preexisting antiepileptic medication may have exacerbated acidosis. Propofol infusion for the treatment of status epilepticus should be carefully weighted against its real risk to develop propofol infusion syndrome, and alternative agents such as benzodiazepines or barbiturates should be considered for first line therapy. If necessary, prolonged propofol infusion at high doses for the treatment of status epilepticus should be used with caution, and in all cases careful monitoring for rhabdomyolysis and acidosis must be performed.
Collapse
Affiliation(s)
- Elena L Zarovnaya
- Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
| | | | | |
Collapse
|
17
|
Ceci M, Gallo P, Santonastasi M, Grimaldi S, Latronico MVG, Pitisci A, Missol-Kolka E, Scimia MC, Catalucci D, Hilfiker-Kleiner D, Condorelli G. Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis. Cell Death Differ 2007; 14:1060-2. [PMID: 17237758 DOI: 10.1038/sj.cdd.4402095] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
18
|
Abstract
Heart failure (HF) has traditionally been divided into HF with a reduced ejection fraction (EF; systolic HF) and HF with a normal EF (diastolic HF). Both groups have reductions in exercise tolerance, neurohumoral activation, and abnormal left ventricular (LV) filling dynamics and impaired relaxation. Although the normal EF indicates that pump performance is adequately compensated, some of the patients with HF and a normal EF have reduced longitudinal systolic velocity indicating cardiac muscular contractile dysfunction. Regardless of EF, the severity of HF and its prognosis and degree of exercise intolerance are closely related to the degree of diastolic filling abnormalities. Patients with HF and a reduced EF have ventricular dilatation and elongated myocytes, whereas patients with HF and a normal EF do not. Thus, patients with HF have diastolic abnormalities regardless of EF and many patients with HF and a normal EF have contractile abnormalities despite preserved systolic pump performance. Heart failure with a normal EF and a reduced EF differs in the systolic LV pump performance and the type of remodeling. The mechanism of the differing remodeling responses is not known, but aging, sex differences, and diabetes may contribute.
Collapse
Affiliation(s)
- Hidekatsu Fukuta
- Cardiology Section, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1045, USA
| | | |
Collapse
|
19
|
Nishi I, Noguchi T, Furuichi S, Iwanaga Y, Kim J, Ohya H, Aihara N, Takaki H, Goto Y. Are Cardiac Events During Exercise Therapy for Heart Failure Predictable From the Baseline Variables? Circ J 2007; 71:1035-9. [PMID: 17587707 DOI: 10.1253/circj.71.1035] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Exercise training (ET) is an emerging therapy for chronic heart failure, but the baseline patient characteristics for predicting cardiac events (CEs) during the course of ET remain unknown. METHODS AND RESULTS Of the 111 stable heart failure patients who participated in a 3-month ET program, 6 withdrew from the program for cardiac reasons and 9 had transient interruptions in the program because of CEs. The baseline clinical characteristics of these 15 patients (CE group) and the remaining 96 patients (No-CE group) were compared. Compared with the No-CE group, the CE group had a significantly higher prevalence of pacemaker/implantable cardioverter-defibrillators, larger left ventricular end-diastolic diameter (LVEDDs), lower peak oxygen uptake, greater ventilation drive, and higher plasma brain natriuretic peptide concentration at baseline. Multivariate logistic regression analysis showed that a larger LVEDD was a significant predictor of the occurrence of a transient interruption to or permanent withdrawal from the ET program because of CEs. Receiver operating characteristic curve analysis demonstrated that an LVEDD > or = 65 mm had a sensitivity of 93% and specificity of 48% in predicting CEs. CONCLUSIONS Patients with a large LVEDD (> or = 65 mm) at baseline should be monitored carefully during the course of an ET program.
Collapse
Affiliation(s)
- Isao Nishi
- Division of Cardiology, National Cardiovascular Center, Suita, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Adrashev AV, Adrashev VN, Iakob OV. [The influence of intracardiac asynchronism on the clinical course of chronic cardiac insufficiency]. Klin Med (Mosk) 2007; 85:31-34. [PMID: 18154176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Intracardiac asynchronism presents systolic and/or diastolic dyscoordination in different myocardial areas within one and/or between different cardiac chambers. QRS complex widening is the marker of electric asynchronism. In 1/3 of patients with chronic cardiac insufficiency (CCI), the width of QRS complex is more than 120 msec. sixty-five CCI patients (56 men aged 63.7 +/- 7.3 years and 9 women aged 66.8 +/- 8.2 years) were divided into two groups: the group with a wide QRS (more than 120 msec) and the group with a narrow QRS (less than 120 msec), 30 and 35 patients, respectively. In the group with a wide QRS, 96.6% of patients suffered from clinically significant CCI (functional class III to IV); in the other group it was observed in 65.7% of patients. The patients were observed during three years. CCI dynamics was evaluated, quality of life was assessed using the Russian version of SF questionnaire, and three-year survival rate was assessed by Kaplan-Meyer method. The presence of electric asynchronism in a form of a wide QRS complex promotes CCI progression, accompanied by CCI functional class deterioration as well as clinical worsening and decreased physical exercise tolerance according to 6-min walking test. The frequency of seeking medical aid was significantly higher among patients with a wide QRS complex.
Collapse
|
21
|
Khalife WI, Kar B. The TandemHeart pVAD in the treatment of acute fulminant myocarditis. Tex Heart Inst J 2007; 34:209-13. [PMID: 17622371 PMCID: PMC1894709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
Acute fulminant myocarditis commonly manifests itself as severe, rapidly progressive hemodynamic deterioration and circulatory collapse that may be resistant to high doses of inotropic agents and steroids and to mechanical support by intra-aortic balloon pump. Acute myocarditis has a high mortality rate and may necessitate heart transplantation. The best short-term therapy available to support the patient may be a percutaneous left ventricular assist device. One such unit, the TandemHeart percutaneous ventricular assist device, can enable patients to recover in a few days. Two of our patients who experienced profound, therapy-resistant heart failure arising from acute myocarditis were successfully supported by the TandemHeart. To the best of our knowledge, these are the 1st reported cases in which the TandemHeart percutaneous ventricular assist device served as a bridge to recovery from acute fulminant myocarditis.
Collapse
MESH Headings
- Acute Disease
- Adult
- Cardiac Catheterization
- Cardiac Output, Low/complications
- Cardiac Output, Low/etiology
- Cardiac Output, Low/pathology
- Cardiac Output, Low/physiopathology
- Cardiac Output, Low/therapy
- Coronary Circulation
- Equipment Design
- Female
- Heart-Assist Devices
- Humans
- Magnetic Resonance Imaging
- Middle Aged
- Myocarditis/complications
- Myocarditis/pathology
- Myocarditis/physiopathology
- Myocarditis/therapy
- Shock, Cardiogenic/etiology
- Shock, Cardiogenic/pathology
- Shock, Cardiogenic/physiopathology
- Shock, Cardiogenic/therapy
- Treatment Outcome
- Ventricular Function, Left
Collapse
Affiliation(s)
- Wissam I Khalife
- Department of Cardiology, Division of Heart Failure/Cardiac Transplantation, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
| | | |
Collapse
|
22
|
Narula J, Haider N, Arbustini E, Chandrashekhar Y. Mechanisms of disease: apoptosis in heart failure--seeing hope in death. ACTA ACUST UNITED AC 2006; 3:681-8. [PMID: 17122801 DOI: 10.1038/ncpcardio0710] [Citation(s) in RCA: 103] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2006] [Accepted: 06/23/2006] [Indexed: 11/08/2022]
Abstract
Apoptosis or programmed cell death is an evolutionarily conserved process of cell death, wherein cells die without provoking significant inflammatory response. There is convincing evidence that apoptosis contributes to the progression of heart failure. Apoptosis occurs through a cascade of subcellular events including cytochrome c release into the cytoplasm and activation of proteolytic caspases. Activated caspases lead to fragmentation of cytoplasmic proteins, including contractile apparatus, to a variable extent. It is proposed that the release of cytochrome c from mitochondria and contractile protein loss in living heart muscle cells contributes to systolic dysfunction. Interestingly, despite extensive changes in the cytoplasm, nuclear damage, which is the final event in apoptosis, is rather infrequent in the failing heart. Since the nucleus remains unaffected and the genetic blueprint intact in cells with interrupted apoptosis, these heart muscle cells might be amenable to cytoplasmic reconstitution. This process of 'apoptosis interruptus' could allow development of novel strategies to reverse or attenuate heart failure.
Collapse
Affiliation(s)
- Jagat Narula
- Division of Cardiology, University of California, Irvine School of Medicine, 101 The City Drive, Building 53, Mail Route 81, Orange, CA 92868, USA.
| | | | | | | |
Collapse
|
23
|
Vercauteren M, Remy E, Devaux C, Dautreaux B, Henry JP, Bauer F, Mulder P, Hooft van Huijsduijnen R, Bombrun A, Thuillez C, Richard V. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 2006; 114:2498-507. [PMID: 17101854 DOI: 10.1161/circulationaha.106.630129] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND Chronic heart failure (CHF) induces endothelial dysfunction characterized by a decrease in nitric oxide (NO) production in response to flow (flow-mediated dilatation [FMD]). Because activation of endothelial NO synthase (eNOS) by flow requires tyrosine phosphorylation, we tested whether endothelial dysfunction could be corrected by increasing phosphotyrosine levels using protein tyrosine phosphatase (PTP) inhibitors and especially inhibitors of PTP1B. METHODS AND RESULTS CHF was induced by coronary ligation in mice, and FMD was assessed in isolated and cannulated mesenteric artery segments (2 mm in length and <300 microm in diameter). CHF almost abolished FMD but only moderately affected the response to acetylcholine. In mice with CHF, the PTP1B inhibitors AS279, AS098, and AS713 restored FMD to levels similar to those of normal mice. This restoration was reduced by inhibitors of eNOS and phosphatidylinositol-3 kinase. Polymerase chain reaction and Western blot showed that arteries express PTP1B, and this expression was not affected by CHF. Immunolocalization revealed the presence of PTP1B in the endothelium and the adventitia. Flow induced a transient eNOS phosphorylation that was absent in CHF. PTP1B inhibition stimulated early eNOS phosphorylation and increased phosphorylation of Akt. CONCLUSIONS Our results demonstrate for the first time that PTP1B inhibitors may be potent treatments for endothelial dysfunction.
Collapse
Affiliation(s)
- Magali Vercauteren
- INSERM U644, Federate Institute for Multidisciplinary Research on Peptides, Rouen University Medical School, Rouen, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
In this era of genomics, new technologies and the information that they generate have a wide range of potential applications to heart failure. Though there has not been widespread practical use of genomic information in everyday practice, there are many examples of how this information is beginning to transform the way we look at disease states in terms of diagnosis, prognosis, and treatment. The experience of oncology and other fields helps inform the heart failure field of not only the use of this information in investigating diagnosis, prognosis, and treatment response, but the reciprocal nature of this information. This information can be clinically useful (for instance, predicting treatment response) as well as further drive laboratory investigation (teasing out the biological pathways in non-responders to treatment can be a focus of new drug discovery); this is the essence of translational medicine. We believe that this is a good time to review where new technologies and information they generate can be placed into our classic understanding of heart failure: that is how we might redefine cardiomyopathy given our new information. Here we will review genomic evidence to date and how it can and may be considered in the evaluation and management of cardiomyopathies.
Collapse
Affiliation(s)
- Mark P Donahue
- Duke University Medical Center Department of Medicine, Division of Cardiovascular Medicine, Durham, North Carolina 27710, USA.
| | | | | |
Collapse
|
25
|
Khush KK, Waters DD. Effects of Statin Therapy on the Development and Progression of Heart Failure: Mechanisms and Clinical Trials. J Card Fail 2006; 12:664-74. [PMID: 17045188 DOI: 10.1016/j.cardfail.2006.05.003] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2006] [Revised: 04/28/2006] [Accepted: 05/01/2006] [Indexed: 11/18/2022]
Abstract
BACKGROUND Statin therapy has been shown to effectively lower low-density lipoprotein cholesterol levels and reduce cardiovascular events. Statins also appear to exert other favorable effects, including anti-inflammatory actions and improvement in endothelial function. Statin therapy may therefore yield important clinical benefits in patients with heart failure-a physiologic state characterized by systemic inflammation and endothelial dysfunction. METHODS AND RESULTS This review summarizes basic and clinical investigations regarding the role of statin therapy in heart failure, focusing on potential mechanisms and preliminary clinical data. There is now extensive evidence suggesting that statins improve endothelial function, inhibit neurohormonal activation, restore autonomic balance, reduce inflammation, and prevent ventricular remodeling. Retrospective and small-scale prospective studies suggest that statins prevent the development of heart failure and reduce mortality in patients with established HF. CONCLUSION Preliminary evidence supports a role for statins in improving surrogate markers and clinical outcomes in ischemic and nonischemic heart failure. Large-scale randomized clinical trials are needed to definitively address this important topic.
Collapse
Affiliation(s)
- Kiran K Khush
- Division of Cardiology, University of California, San Francisco School of Medicine, San Francisco, California 94143, USA
| | | |
Collapse
|
26
|
Verbyts'kyĭ VV. [Morphology of disruptions of energy and plastic provisions of the myocardium in chronic coronary insufficiency]. Lik Sprava 2006:31-5. [PMID: 17312884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
The structural and metabolic reorganisation of the myocardium at disruption of energy and plastic provisions of myocardium functions were addressed in this study with the help of a complex of ultrastructural and cytochemical techniques. These disruption are a fundamental stage in pathogenesis of the ischemic alteration at chronic coronary insufficiency.
Collapse
|
27
|
Abstract
Duchenne muscular dystrophy (DMD) is a lethal degenerative disease of skeletal muscle, characterized by the absence of the cytoskeletal protein dystrophin. Some DMD patients show a dilated cardiomyopathy leading to heart failure. This study explores the possibility that dystrophin is involved in the regulation of a stretch-activated channel (SAC), which in the absence of dystrophin has increased activity and allows greater Ca(2+) into cardiomyocytes. Because cardiac failure only appears late in the progression of DMD, we examined age-related effects in the mdx mouse, an animal model of DMD. Ca(2+) measurements using a fluorescent Ca(2+)-sensitive dye fluo-4 were performed on single ventricular myocytes from mdx and wild-type mice. Immunoblotting and immunohistochemistry were performed on whole hearts to determine expression levels of key proteins involved in excitation-contraction coupling. Old mdx mice had raised resting intracellular Ca(2+) concentration ([Ca(2+)](i)). Isolated ventricular myocytes from young and old mdx mice displayed abnormal Ca(2+) transients, increased protein expression of the ryanodine receptor, and decreased protein expression of serine-16-phosphorylated phospholamban. Caffeine-induced Ca(2+) transients showed that the Na(+)/Ca(2+) exchanger function was increased in old mdx mice. Two SAC inhibitors streptomycin and GsMTx-4 both reduced resting [Ca(2+)](i) in old mdx mice, suggesting that SACs may be involved in the Ca(2+)-handling abnormalities in these animals. This finding was supported by immunoblotting data, which demonstrated that old mdx mice had increased protein expression of canonical transient receptor potential channel 1, a likely candidate protein for SACs. SACs may play a role in the pathogenesis of the heart failure associated with DMD. Early in the disease process and before the onset of clinical symptoms increased, SAC activity may underlie the abnormal Ca(2+) handling in young mdx mice.
Collapse
MESH Headings
- Age Factors
- Animals
- Caffeine/pharmacology
- Calcium/metabolism
- Calcium-Binding Proteins/metabolism
- Cardiac Output, Low/etiology
- Cardiac Output, Low/metabolism
- Cardiac Output, Low/pathology
- Cardiac Output, Low/physiopathology
- Cardiomyopathy, Dilated/etiology
- Cardiomyopathy, Dilated/metabolism
- Cardiomyopathy, Dilated/pathology
- Cardiomyopathy, Dilated/physiopathology
- Disease Models, Animal
- Electric Stimulation
- Fibrosis
- Heart Ventricles/metabolism
- Heart Ventricles/physiopathology
- Intercellular Signaling Peptides and Proteins
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Inbred mdx
- Muscular Dystrophy, Animal/complications
- Muscular Dystrophy, Duchenne/complications
- Myocardial Contraction
- Myocytes, Cardiac/drug effects
- Myocytes, Cardiac/metabolism
- Peptides/pharmacology
- Phosphorylation
- Ryanodine Receptor Calcium Release Channel/metabolism
- Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism
- Sodium-Calcium Exchanger/drug effects
- Sodium-Calcium Exchanger/metabolism
- Spider Venoms/pharmacology
- Streptomycin/pharmacology
- TRPC Cation Channels/drug effects
- TRPC Cation Channels/metabolism
- Time Factors
Collapse
Affiliation(s)
- Iwan A Williams
- Bosch Institute, School of Medical Sciences, University of Sydney F13, NSW 2006 Australia
| | | |
Collapse
|
28
|
Ooi OC, Al Habib HF, Almsherqi ZA, El Oakley RM. Stem cell transplantation: potential impact on heart failure. Cell Tissue Bank 2006; 7:307-17. [PMID: 16955341 DOI: 10.1007/s10561-006-9007-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2005] [Accepted: 01/10/2006] [Indexed: 01/14/2023]
Abstract
Cell transplantation is a promising new modality in treating damaged myocardium after myocardial infarction and in preventing postmyocardial infarction LV remodelling. Two strategies are plausible: the first uses adult tissue stem cells to replace the scar tissues and amend the lost myocardium, whilst the second strategy uses embryonic stem cells in an attempt to regenerate myocardium and/or blood vessels.
Collapse
Affiliation(s)
- Oon Cheong Ooi
- Department of Cardiac, Thoracic and Vascular Surgery, The Heart Institute, National Healthcare Group, National University Hospital, Singapore, Singapore
| | | | | | | |
Collapse
|
29
|
Abstract
Although the negative inotropic effects of both acute and chronic ethanol (EtOH) exposure are well known, little is known concerning the acute-to-chronic transition of such effects. In this study, our objective was to address this question by detailing the effects that acute EtOH exposure induces on cellular excitation-contraction (EC) coupling and, subsequently, comparing whether and how such changes translate to the early chronic EtOH condition in a rat model known to develop alcohol-induced cardiomyopathy. Acute EtOH exposure, as formerly reported, indeed induced dose-dependent negative inotropic changes in cellular EC coupling, manifest as reductions in cell shortening, Ca2+ transient amplitude, Ca2+ decay rate, and sarcoplasmic reticulum Ca2+ content of isolated rat ventricular cardiac myocytes. Supplementary to this, we found Ca2+ spark character not to be significantly affected by acute EtOH exposure. In contrast, the results obtained from cardiac myocytes isolated from rats fed a diet containing ∼9% (vol/vol) EtOH for 1 mo revealed changes in these parameters reflecting positive inotropy, whereas at 3 mo, these parameters again reflected negative inotropy similar but not identical to that induced by acute EtOH exposure. No significant changes were evident at either 1- or 3-mo chronic EtOH administration in echocardiographic parameters known to be perturbed in alcoholic cardiomyopathy (ACM), thus indicating that we were examining an asymptomatic stage in chronic EtOH administration consistent with an acute-to-chronic transition phase. Continued study of such transition-phase events should provide important insight into which molecular-cellular components of EC coupling play pivotal roles in EtOH-induced disease processes, such as ACM.
Collapse
Affiliation(s)
- Gary L Aistrup
- Department of Molecular Pharmacology & Biological Chemistry, Northwestern University, Feinberg School of Medicine, 303 E. Chicago Ave., Chicago, IL 60611, USA.
| | | | | | | |
Collapse
|
30
|
Batlle M, Roig E, Perez-Villa F, Lario S, Cejudo-Martin P, García-Pras E, Ortiz J, Roqué M, Orús J, Rigol M, Heras M, Ramírez J, Jimenez W. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. J Heart Lung Transplant 2006; 25:1117-25. [PMID: 16962475 DOI: 10.1016/j.healun.2006.04.012] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2006] [Revised: 04/20/2006] [Accepted: 04/24/2006] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND The activation of the renin-angiotensin system (RAS) contributes to the progression of left ventricular dysfunction. A novel human homologue of the angiotensin-converting enzyme (ACE), named ACE2, has been described but its role in human heart failure (HF) has not been elucidated. Besides, there is controversy as to whether the major angiotensin II-forming-activity in heart is ACE or chymase released from mast cells. Furthermore, long-term blockade of nitric oxide (NO) synthesis has been shown to increase ACE activity. To assess the locally activated vasoactive mediators that may contribute to the ventricular deterioration process, we sought to simultaneously analyze their expression in failing hearts. METHODS We analyzed left ventricular biopsies from 30 patients with heart failure undergoing heart transplantation and 12 organ donors. The mRNA levels of ACE, ACE2, chymase and endothelial nitric oxide synthase (eNOS), were quantified by real-time polymerase chain reaction and mast cell density was assessed by immunohistochemistry. The mRNA levels of the atrial natriuretic peptide (ANP) and the brain natriuretic peptide (BNP) were also quantified as controls. RESULTS There was higher ACE and chymase mRNA expression and mast cell density in failing than in control myocardium and no changes in ACE2 expression were detected. eNOS mRNA levels were lower in failing hearts. Both ANP and BNP expression were higher in pathological than in control samples. CONCLUSIONS These data document a decompensation of vasoactive systems that may contribute to the progressive impairment of the myocardial function in HF. On the other hand, ACE2 mRNA expression is not altered in human end-stage HF.
Collapse
MESH Headings
- Adult
- Aged
- Angiotensin-Converting Enzyme 2
- Atrial Natriuretic Factor/genetics
- Atrial Natriuretic Factor/metabolism
- Biopsy
- Cardiac Output, Low/genetics
- Cardiac Output, Low/metabolism
- Cardiac Output, Low/pathology
- Cell Count
- Chymases
- Disease Progression
- Female
- Gene Expression Regulation
- Gene Expression Regulation, Enzymologic
- Humans
- Male
- Mast Cells/metabolism
- Mast Cells/pathology
- Middle Aged
- Natriuretic Peptide, Brain/genetics
- Natriuretic Peptide, Brain/metabolism
- Nitric Oxide Synthase Type III/genetics
- Nitric Oxide Synthase Type III/metabolism
- Peptidyl-Dipeptidase A/genetics
- Peptidyl-Dipeptidase A/metabolism
- RNA, Messenger/genetics
- RNA, Messenger/metabolism
- Renin-Angiotensin System/genetics
- Renin-Angiotensin System/physiology
- Serine Endopeptidases/genetics
- Serine Endopeptidases/metabolism
- Ventricular Dysfunction, Left/genetics
- Ventricular Dysfunction, Left/metabolism
- Ventricular Dysfunction, Left/pathology
Collapse
Affiliation(s)
- Montserrat Batlle
- Experimental Cardiology Laboratory, Hospital Clínic de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
|
32
|
van Haelst PL, Brügemann J, Diercks GF, Suurmeijer A, van Veldhuisen DJ. Serial right ventricular endomyocardial biopsy in rapid-onset severe heart failure due to giant cell myocarditis. Cardiovasc Pathol 2006; 15:228-30. [PMID: 16844555 DOI: 10.1016/j.carpath.2006.03.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2005] [Revised: 03/14/2006] [Accepted: 03/23/2006] [Indexed: 11/30/2022] Open
Abstract
Giant cell myocarditis (GCM) is a serious condition that warrants immediate diagnosis and treatment. It often presents as rapidly progressive heart failure and/or malignant ventricular arrhythmias. Here, we describe a 34-year-old patient with myasthenia gravis who presented with GCM 2 weeks after resection of a thymoma. A cardiac biopsy confirming the diagnosis was done within 3 days after admission. After institution of an aggressive immunosuppressive drug regimen, implantation of an implantable cardioverter defibrillator, and intensive cardiac rehabilitation, the patient recovered dramatically. In control biopsies after 4 weeks and 6 months, no more giant cells were found. We conclude that, in the case of nonischemic acute heart failure in young patients, a biopsy should be performed as soon as possible to prevent an unfavourable outcome of this often fatal disease.
Collapse
Affiliation(s)
- Paul L van Haelst
- Department of Cardiology, University Medical Center Groningen, NL-9700RB Groningen, The Netherlands.
| | | | | | | | | |
Collapse
|
33
|
Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A 2006; 103:10086-91. [PMID: 16775082 PMCID: PMC1502510 DOI: 10.1073/pnas.0603615103] [Citation(s) in RCA: 301] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Heart failure is accompanied by important defects in metabolism. The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) is a powerful regulator of mitochondrial biology and metabolism. PGC-1alpha and numerous genes regulated by PGC-1alpha are repressed in models of cardiac stress, such as that generated by transverse aortic constriction (TAC). This finding has suggested that PGC-1alpha repression may contribute to the maladaptive response of the heart to chronic hemodynamic loads. We show here that TAC in mice genetically engineered to lack PGC-1alpha leads to accelerated cardiac dysfunction, which is accompanied by signs of significant clinical heart failure. Treating cardiac cells in tissue culture with the catecholamine epinephrine leads to repression of PGC-1alpha and many of its target genes, recapitulating the findings in vivo in response to TAC. Importantly, introduction of ectopic PGC-1alpha can reverse the repression of most of these genes by epinephrine. Together, these data indicate that endogenous PGC-1alpha serves a cardioprotective function and suggest that repression of PGC-1alpha significantly contributes to the development of heart failure. Moreover, the data suggest that elevating PGC-1alpha activity may have therapeutic potential in the treatment of heart failure.
Collapse
Affiliation(s)
- Zoltan Arany
- *Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and
| | - Mikhail Novikov
- Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215
| | - Sherry Chin
- *Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and
| | - Yanhong Ma
- *Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and
| | - Anthony Rosenzweig
- Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215
| | - Bruce M. Spiegelman
- *Dana–Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115; and
| |
Collapse
|
34
|
Abstract
BACKGROUND The early phase of action potential (AP) repolarization is critical to impulse conduction in the heart because it provides current for charging electrically coupled cells. In the present study we tested the impact of heart failure-associated electrical remodeling on AP propagation. METHODS AND RESULTS Subepicardial, midmyocardial, and subendocardial myocytes were enzymatically dissociated from control and pressure-overload failing left ventricle (LV), and APs were recorded. A unique coupling-clamp technique was used to electrically couple 2 isolated myocytes with a controlled value of coupling conductance (Gc). In sham-operated mice, AP duration manifested a clear transmural gradient, with faster repolarization in subepicardial myocytes than in subendocardial myocytes. AP propagation from subendocardial to subepicardial myocytes required less Gc compared with conduction in the opposite direction. In failing heart, AP morphology was dramatically altered, with a significantly elevated plateau potential and prolonged AP duration. Spatially nonuniform alteration of AP duration in failing heart blunted the transmural gradient of repolarization. Furthermore, increased pacing rate prolonged AP duration exclusively in myocytes from failing heart, and the critical conductance required for successful AP propagation decreased significantly at high frequencies. Finally, in failing heart, asymmetry of transmural electrical propagation was abolished. CONCLUSIONS In failing heart, preferential conduction from subendocardial to subepicardial myocytes is lost, and failing myocytes manifest facilitated AP propagation at fast rates. Together, these electrical remodeling responses may promote conduction of premature impulses and heighten the risk of malignant arrhythmia, a prominent feature of heart failure.
Collapse
Affiliation(s)
- Yanggan Wang
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
| | | | | | | | | |
Collapse
|
35
|
Abstract
The impact of hypertension on left ventricular (LV) structure, pump function, and heart failure in Dahl salt-sensitive rats is poorly characterized but hypothesized to yield insights into the pathophysiology of heart failure with normal or preserved ejection fraction. Eighty Dahl salt-sensitive rats were fed either a high-salt (HS) or low-salt (LS, controls) diet starting at age 7 weeks. Ventricular properties were measured by echocardiography, hemodynamics and end-systolic and end-diastolic pressure-volume relationships (ESPVR and EDPVR, respectively). Compared with LS controls, HS rats developed severe hypertension and LV hypertrophy. At week 12, HS rats developed passive diastolic dysfunction (leftward/upward shifted EDPVR, increased chamber stiffness) with reductions in end-diastolic volume. However, the ESPVR also shifted upward (enhanced end-systolic function) so that overall pump function was enhanced compared with LS, and there was no change in end-diastolic pressure (EDP). At 16 and 20 weeks, HS hearts enlarged so that end-diastolic volumes and EDPVRs became similar to the respective age-matched LS controls. Concomitantly, the ESPVRs and overall pump function curves also moved toward controls, and ejection fraction declined. Despite normal or enhanced overall pump function at these times, EDP and wet lung weight increased, indicative of development of heart failure. In the Dahl salt-sensitive rat, which pathophysiologically retains salt and water, the development of heart failure (increased EDP and wet lung weight) is dissociated from changes in passive diastolic and active systolic properties. These observations suggest that a volume overload sate plays an important pathophysiological role in development of heart failure despite preserved overall ventricular pump function in this model of chronic hypertension.
Collapse
Affiliation(s)
- Stefan Klotz
- Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
| | | | | | | | | | | |
Collapse
|
36
|
Gill RM, Jones BD, Corbly AK, Ohad DG, Smith GD, Sandusky GE, Christe ME, Wang J, Shen W. Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure induced by chronic coronary microembolization. Life Sci 2006; 79:536-44. [PMID: 16624328 DOI: 10.1016/j.lfs.2006.01.045] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2005] [Revised: 09/27/2005] [Accepted: 01/24/2006] [Indexed: 12/27/2022]
Abstract
The role of the Frank-Starling mechanism in the regulation of cardiac systolic function in the ischemic failing heart was examined in conscious dogs. Left ventricular (LV) dimension, pressure and systolic function were assessed using surgically implanted instrumentations and non-invasive echocardiogram. Heart failure was induced by daily intra-coronary injections of microspheres for 3-4 weeks via implanted coronary catheters. Chronic coronary embolization resulted in a progressive dilation of the left ventricle (12+/-3%), increase in LV end-diastolic pressure (118+/-19%), depression of LV dP/dt(max) (-19+/-4%), fractional shortening (-36+/-7%), and cardiac work (-60+/-9%), and development of heart failure, while the LV contractile response to dobutamine was depressed. A brief inferior vena caval occlusion in dogs with heart failure decreased LV preload to match the levels attained in their control state and caused a further reduction of LV dP/dt(max), fractional shortening, stroke work and cardiac work. Moreover, in response to acute volume loading, the change in the LV end-diastolic dimension-pressure (DeltaLVEDD-DeltaLVEDP) curve in the failing heart became steeper and shifted significantly to the left, while the increases in LV stroke work and cardiac work were blunted. Thus, our results suggest that the Frank-Starling mechanism is exhausted in heart failure and unable to further respond to increasing volume while it plays an important compensatory role in adaptation to LV dysfunction in heart failure.
Collapse
Affiliation(s)
- Robert M Gill
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Emmrich P, Ogunlade V, Gradistanac T, Daneschnejad S, Koch MC, Schober R. [Facioscapulohumeral muscle dystrophy and heart disease]. ACTA ACUST UNITED AC 2005; 94:348-54. [PMID: 15868364 DOI: 10.1007/s00392-005-0223-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2004] [Accepted: 12/28/2004] [Indexed: 10/25/2022]
Abstract
Cardiac involvement is well known in a number of skeletomuscular diseases but not in facio-scapulohumeral muscular dystrophy (FSHD). We report on a 71 year old woman with progressive cardiac insufficiency in FSHD, which was also confirmed by molecular analysis in one of the two daughters affected by the disease. Autopsy of the deceased patient showed the typical changes in skeletal muscles including focal inflammatory infiltrates in the diaphragm and, in addition, cardiac muscular involvement. The histological changes resembled those seen in primary cardiomyopathy despite the normal muscle mass volume. Both clinically and morphologically, the cardiac disease was the cause of death in this patient with FSHD.
Collapse
MESH Headings
- Aged
- Cardiac Output, Low/diagnosis
- Cardiac Output, Low/genetics
- Cardiac Output, Low/pathology
- Cardiomyopathies/diagnosis
- Cardiomyopathies/genetics
- Cardiomyopathies/pathology
- Chromosome Aberrations
- Chromosome Deletion
- Chromosomes, Human, Pair 4
- Female
- Genes, Dominant
- Heart Failure/diagnosis
- Heart Failure/genetics
- Heart Failure/pathology
- Humans
- Muscle, Skeletal/pathology
- Muscular Dystrophy, Facioscapulohumeral/diagnosis
- Muscular Dystrophy, Facioscapulohumeral/genetics
- Muscular Dystrophy, Facioscapulohumeral/pathology
- Myocardium/pathology
- Pedigree
- Pulmonary Embolism/diagnosis
- Pulmonary Embolism/genetics
- Pulmonary Embolism/pathology
- Ventricular Dysfunction, Left/diagnosis
- Ventricular Dysfunction, Left/genetics
- Ventricular Dysfunction, Left/pathology
Collapse
Affiliation(s)
- P Emmrich
- Selbst. Abt. für Neuropathologie, Institut für Pathologie des Universitätsklinikums Leipzig (AöR), Liebigstr. 26, 04103 Leipzig, Germany
| | | | | | | | | | | |
Collapse
|
38
|
Kubalova Z, Terentyev D, Viatchenko-Karpinski S, Nishijima Y, Györke I, Terentyeva R, da Cuñha DNQ, Sridhar A, Feldman DS, Hamlin RL, Carnes CA, Györke S. Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci U S A 2005; 102:14104-9. [PMID: 16172392 PMCID: PMC1236548 DOI: 10.1073/pnas.0504298102] [Citation(s) in RCA: 162] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2005] [Accepted: 08/04/2005] [Indexed: 12/11/2022] Open
Abstract
Diminished Ca release from the sarcoplasmic reticulum (SR) is an important contributor to the impaired contractility of the failing heart. Despite extensive effort, the underlying causes of abnormal SR Ca release in heart failure (HF) remain unknown. We used a combination of simultaneous imaging of cytosolic and SR intraluminal [Ca] in isolated cardiomyocytes and recordings from single-ryanodine receptor (RyR) channels reconstituted into lipid bilayers to investigate alterations in intracellular Ca handling in an experimental model of chronic HF. We found that diastolic free [Ca] inside the SR was dramatically reduced because of a Ca leak across the SR membrane, mediated by spontaneous local release events (Ca sparks), in HF myocytes. Additionally, the magnitudes of intrastore Ca depletion signals during global and focal Ca release events were blunted, and [Ca]SR recovery was slowed after global but not focal Ca release in HF myocytes. At the single-RyR level, the sensitivity of RyRs to activation by luminal Ca was greatly enhanced, providing a molecular mechanism for the maintained potentiation of Ca sparks (and increased Ca leak) at reduced intra-SR [Ca] in HF. This work shows that the diminished SR Ca release characteristic of failing myocardium could be explained by increased sensitivity of RyRs to luminal Ca, leading to enhanced spark-mediated SR Ca leak and reduced intra-SR [Ca].
Collapse
Affiliation(s)
- Zuzana Kubalova
- Department of Physiology and Cell Biology, Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH 43210, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Abstract
Background Ascites is one of the most common complications of liver diseases, even though in 15% of the cases it is related to extrahepatic diseases; 3% are of cardiac nature and they appear associated with signs and symptoms of heart failure. Case presentation A 70 year old man was admitted with more than one year history of abdominal distension and a weight gain of 10 kilograms. He is asymptomatic and walks 2000–3000 meters a day without angor or dyspnea. The physical examination shows moderate abdominal distension, with no hepatosplenomegaly or edema, and there is mild jugular vein distension. The studies performed (complete laboratory work up, paracentesis, liver biopsy, echocardiogram, intrahepatic pressure measurements, etc.) showed a chylous ascites related to portal hypertension, and left ventricular dysfunction was the only probable cause found. Conclusion Asymptomatic heart dysfunction can mimic liver disease and should be kept in mind as a cause of chylous ascites.
Collapse
Affiliation(s)
- Ezequiel Ridruejo
- Hepatology Section, Department of Internal Medicine, Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC), Las Heras 2939, (1425), Buenos Aires, Argentina
| | - Oscar G Mandó
- Hepatology Section, Department of Internal Medicine, Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC), Las Heras 2939, (1425), Buenos Aires, Argentina
| |
Collapse
|
40
|
Kim-Mitsuyama S, Izumi Y, Izumiya Y, Yoshida K, Yoshiyama M, Iwao H. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model. Hypertens Res 2005; 27:771-9. [PMID: 15785013 DOI: 10.1291/hypres.27.771] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The present study was undertaken to examine the effects of a calcium channel blocker, azelnidipine (1 mg/kg/day), an angiotensin converting enzyme (ACE) inhibitor, temocapril (10 mg/kg/day), an angiotensin II type 1 (AT1) receptor blocker (ARB), olmesartan (5 mg/kg/day), and their combination on Dahl salt-sensitive rats (DS rats) developing heart failure with preserved systolic function. DS rats were fed a high-salt diet (8% NaCl) from 7 weeks of age and progressively developed hypertension. Although monotherapy with azelnidipine lowered the blood pressure of DS rats to a greater extent than monotherapy with temocapril or olmesartan, the three drugs had similar effects on cardiac hypertrophy, cardiac fibrosis, the expressions of brain natriuretic peptide, transforming growth factor-beta1, collagen I, collagen III and monocyte chemoattractant protein-1 mRNA (as estimated by Northern blot analysis), and cardiac diastolic dysfunction (as estimated by echocardiography). These results show that ACE and AT1 receptor, as well as hypertension, are involved in the development of heart failure with preserved systolic function in DS rats. The combination of azelnidipine with olmesartan or temocapril produced no additive hypotensive effect in DS rats and no additive effect on cardiac hypertrophy or gene expressions. However, the combination therapy prolonged the survival rate of DS rats more than azelnidipine (p <0.01) or temocapril alone (p <0.05), and this additive beneficial effect by the combination therapy was associated with a greater reduction of cardiac fibrosis, urinary albumin excretion and serum creatinine. Our results thus showed that the combination of a calcium channel blocker with an ARB or an ACE inhibitor had additive preventive effects on a rat model of hypertensive heart failure with preserved systolic function. Thus, combination therapy with these agents seems to be a useful therapeutic strategy for the prevention of hypertensive heart failure.
Collapse
Affiliation(s)
- Shokei Kim-Mitsuyama
- Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
| | | | | | | | | | | |
Collapse
|
41
|
|
42
|
Abstract
There is growing evidence that the altered production and/or spatiotemporal distribution of reactive oxygen and nitrogen species creates oxidative and/or nitrosative stresses in the failing heart and vascular tree, which contribute to the abnormal cardiac and vascular phenotypes that characterize the failing cardiovascular system. These derangements at the integrated system level can be interpreted at the cellular and molecular levels in terms of adverse effects on signaling elements in the heart, vasculature, and blood that subserve cardiac and vascular homeostasis.
Collapse
Affiliation(s)
- Joshua M Hare
- Johns Hopkins University School of Medicine, Department of Medicine, Cardiology Division, Baltimore, Maryland 21205, USA.
| | | |
Collapse
|
43
|
Abstract
A constant supply of oxygen is indispensable for cardiac viability and function. However, the role of oxygen and oxygen-associated processes in the heart is complex, and they and can be either beneficial or contribute to cardiac dysfunction and death. As oxygen is a major determinant of cardiac gene expression, and a critical participant in the formation of ROS and numerous other cellular processes, consideration of its role in the heart is essential in understanding the pathogenesis of cardiac dysfunction.
Collapse
Affiliation(s)
- Frank J Giordano
- Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
| |
Collapse
|
44
|
Abstract
Recently, low--but abnormal--rates of cardiomyocyte apoptosis have been observed in failing human hearts. Genetic and pharmacological studies suggest that this cell death is causally linked to heart failure in rodent models. Herein, we review these data and discuss potential therapeutic implications.
Collapse
Affiliation(s)
- Roger S-Y Foo
- Department of Medicine, Cardiovascular Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA
| | | | | |
Collapse
|
45
|
Abstract
In response to acute and chronic stresses, the heart frequently undergoes a remodeling process that is accompanied by myocyte hypertrophy, impaired contractility, and pump failure, often culminating in sudden death. The existence of redundant signaling pathways that trigger heart failure poses challenges for therapeutic intervention. Cardiac remodeling is associated with the activation of a pathological gene program that weakens cardiac performance. Thus, targeting the disease process at the level of gene expression represents a potentially powerful therapeutic approach. In this review, we describe strategies for normalizing gene expression in the failing heart with small molecules that control signal transduction pathways directed at transcription factors and associated chromatin-modifying enzymes.
Collapse
|
46
|
Mishnev OD, Tverskaia MS, Karpova VV, Chumakova MA, Izmaĭlova NS, Kadyrova MK, Abdulkerimova NZ, Kliuchikova VI. [Histochemical characteristics of adrenergic myocardial and adrenal fibers in experimental narrowing of the aorta and pulmonary artery]. Arkh Patol 2005; 67:21-4. [PMID: 16075607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Ligation of the aorta or the pulmonary trunk was the method of experimental overloading of heart ventricles. Histochemical studies indicated activation of mediator chain of the sympatho-adrenal system. Catecholamines content in the nervous plexus of the overloaded ventricle did not change but there was an increase of their content in the medullary layer of the adrenals. Thus, chromaffin cells activity increases and desympathization of the heart muscle may be an important step in pathogenesis of heart failure in acute arterial hypertension.
Collapse
|
47
|
Liu FF, Stone JR, Schuldt AJT, Okoshi K, Okoshi MP, Nakayama M, Ho KKL, Manning WJ, Marchionni MA, Lorell BH, Morgan JP, Yan X. Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol 2005; 289:H660-6. [PMID: 15833803 DOI: 10.1152/ajpheart.00268.2005] [Citation(s) in RCA: 88] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Neuregulins and their erbB receptors are essential for cardiac development and postulated to be cardioprotective in the presence of injury in the postnatal heart. We tested the hypothesis that the development of doxorubicin-induced cardiotoxicity in vivo is more severe in mice with heterozygous knockout of the neuregulin-1 gene (NRG-1(+/-)) compared with wild-type mice (WT). Three-month old NRG-1(+/-) and WT mice were injected with a single dose of doxorubicin (20 mg/kg ip). Survival was analyzed by the Kaplan-Meier approach. Left ventricular (LV) function and signaling pathways were analyzed 4 days after treatment. Fifteen days after treatment, survival was significantly lower in doxorubicin-treated NRG-1(+/-) mice (NRG-1(+/-)-Dox) compared with doxorubicin-treated WT mice (WT-Dox) (15% vs. 33%, P < 0.01). LV mass was significantly lower in NRG-1(+/-)-Dox but not in WT-Dox compared with nontreated animals. LV systolic pressure and LV midwall fractional shortening were significantly lower in NRG-1(+/-)-Dox compared with WT-Dox mice. LV protein levels of NRG-1, erbB2, and erbB4 receptors were similar in WT-Dox and NRG-1(+/-)-Dox mice. However, levels of phosphorylated erbB2, Akt, and ERK-1/2 were significantly decreased in NRG-1(+/-)-Dox compared with WT-Dox mice. A significant decrease in phosphorylated P70S6K levels was also observed in NRG-1(+/-)-Dox compared with nontreated NRG-1(+/-) mice. These results demonstrate that heterozygous knockout of the neuregulin-1 gene worsens survival and LV function in the presence of doxorubicin-induced cardiac injury in vivo. This is associated with the depression of activation of the erbB2 receptor as well as Akt, p70S6K, and ERK-1/2 pathways.
Collapse
Affiliation(s)
- Fen-Fen Liu
- Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Rm. SL-221, Boston, MA 02215, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Torrent-Guasp F, Kocica MJ, Corno AF, Komeda M, Carreras-Costa F, Flotats A, Cosin-Aguillar J, Wen H. Towards new understanding of the heart structure and function. Eur J Cardiothorac Surg 2005; 27:191-201. [PMID: 15691670 DOI: 10.1016/j.ejcts.2004.11.026] [Citation(s) in RCA: 162] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2004] [Revised: 11/25/2004] [Accepted: 11/26/2004] [Indexed: 11/24/2022] Open
Abstract
Structure and function in any organ are inseparable categories, both in health and disease. Whether we are ready to accept, or not, many questions in cardiovascular medicine are still pending, due to our insufficient insight in the basic science. Even so, any new concept encounters difficulties, mainly arising from our inert attitude, which may result either in unjustified acceptance or denial. The ventricular myocardial band concept, developed over the last 50 years, has revealed unavoidable coherence and mutual coupling of form and function in the ventricular myocardium. After more than five centuries long debate on macroscopic structure of the ventricular myocardium, this concept has provided a promising ground for its final understanding. Recent validations of the ventricular myocardial band, reviewed here, as well as future research directions that are pointed out, should initiate much wider scientific interest, which would, in turn, lead to reconciliation of some exceeded concepts about developmental, electrical, mechanical and energetical events in human heart. The benefit of this, of course, would be the most evident in the clinical arena.
Collapse
|
49
|
Moreno PL, Wender OB, Barra M, Pellanda LC, Rohde LE, Clausell N. Endomyocardial biopsy foretells ventricular function recovery after coronary artery bypass grafting. Arq Bras Cardiol 2004; 83:379-84; 373-8. [PMID: 15543357 DOI: 10.1590/s0066-782x2004001700004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
OBJECTIVE Patients with ischemic heart failure may benefit from coronary artery bypass grafting. The histopathological variables associated with improvement in ejection fraction 6 months after surgery were assessed. METHODS This study comprised 24 patients indicated for coronary artery bypass grafting, ejection fraction < 35%, functional class II-IV heart failure, and mean age 59 +/- 9 years. Endomyocardial biopsies were performed during and 6 months after surgery. Extension of the fibrosis, number of cells with myocytolysis, and hypertrophy of the muscle fiber were quantified by using a system of image analysis. Clinical and functional review was repeated within 6 months. RESULTS A significant improvement in heart failure functional class was observed in 16 patients after 6 months of follow-up (from NYHA functional class 2.8 +/- 0.7 to 1.7 +/- 0.6; P < 0.001), but the ejection fraction did not change (25 +/- 6 % vs. 26 +/- 10%). Hypertrophy of the muscle fiber was similar in the specimens biopsied in the pre- and postoperative periods (21 +/- 4 vs. 22 +/- 4 microm), but the extension of fibrosis (8 +/- 8 vs. 21 +/- 15% area) and the number of cells with myocytolysis (9 +/- 11 vs. 21 +/- 15% cell) significantly increased. However, the composition of a histological score combining those 3 variables indicated a greater increase in the ventricular function of those with a lower degree of preoperative histopathological alterations. CONCLUSION Patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting improved their ventricular function when the preoperative adverse histopathological alterations were of a lower degree.
Collapse
Affiliation(s)
- Paulo L Moreno
- Instituto de Cardiologia do RS, Fundação Universitária de Cardiologia, Fundação Federal de Ciências Médicas de Porto Alegre, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
| | | | | | | | | | | |
Collapse
|
50
|
Samsonidze EG, Karsanov NV. Elastic modulus of the thin filament under normal conditions and during heart failure. Bull Exp Biol Med 2004; 137:435-9. [PMID: 15455111 DOI: 10.1023/b:bebm.0000038146.83562.b2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We developed an original approach to prepare samples for electron microscopy in electric field allowing calculation of the Youngs modulus of the thin filament in a direction perpendicular to the axis of the filament (longitudinal to the protomer) under normal conditions and during heart failure induced by 10-day toxic and allergic myocarditis. Electric field stretches thin filaments in the transverse direction and the increase in its diameter linearly depends on the applied voltage. The elastic modulus was in inverse proportion to the applied voltage. We found that during heart failure thin filament had an extreme conformation and to a great extent lost its mobility.
Collapse
Affiliation(s)
- E G Samsonidze
- N. V. Karsanov Republican Research Center for Medical Biophysics and New Biomedical Technologies, Tbilisi
| | | |
Collapse
|